Hanmi Science Balance Sheet Health
Financial Health criteria checks 3/6
Hanmi Science has a total shareholder equity of ₩816.0B and total debt of ₩213.0B, which brings its debt-to-equity ratio to 26.1%. Its total assets and total liabilities are ₩1,252.9B and ₩436.9B respectively. Hanmi Science's EBIT is ₩56.0B making its interest coverage ratio 5.8. It has cash and short-term investments of ₩31.5B.
Key information
26.1%
Debt to equity ratio
₩212.98b
Debt
Interest coverage ratio | 5.8x |
Cash | ₩31.55b |
Equity | ₩816.02b |
Total liabilities | ₩436.85b |
Total assets | ₩1.25t |
Recent financial health updates
Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt
Jan 05Recent updates
Is Hanmi Science (KRX:008930) Using Too Much Debt?
Apr 29Hanmi Science Co., Ltd.'s (KRX:008930) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?
Jan 31We Think Hanmi Science (KRX:008930) Can Stay On Top Of Its Debt
Jan 05Shareholders Are Thrilled That The Hanmi Science (KRX:008930) Share Price Increased 100%
Dec 06Financial Position Analysis
Short Term Liabilities: A008930's short term assets (₩271.1B) do not cover its short term liabilities (₩394.3B).
Long Term Liabilities: A008930's short term assets (₩271.1B) exceed its long term liabilities (₩42.6B).
Debt to Equity History and Analysis
Debt Level: A008930's net debt to equity ratio (22.2%) is considered satisfactory.
Reducing Debt: A008930's debt to equity ratio has increased from 6.2% to 26.1% over the past 5 years.
Debt Coverage: A008930's debt is not well covered by operating cash flow (11.4%).
Interest Coverage: A008930's interest payments on its debt are well covered by EBIT (5.8x coverage).